Nearly 1400 people took part in national ‘Walk MS 2025′
Despite a rainy weekend, the weather certainly held out long enough for 'Walk MS 2025.'
It's part of a national annual event that raises awareness and funds for the fight against multiple sclerosis.
In Boston, participants walked along a one to three-mile route, overlooking the harbor, before finishing up at the UMass Boston campus.
Multiple Sclerosis is a disease that affects a person's nervous system. Symptoms can often vary from person to person, including numbness and tingling to mobility challenges, blindness, and paralysis.
Multiple Sclerosis affects an estimated 1 million people in the United States.
Lori Espino, President of the National MS Society Greater New England Chapter, reflected on the walk.
'We had close to 1400 people come out either supporting a loved one with MS or living with MS themselves, and we raised over half a million dollars for a cure.'
Sunday's walk was the sixth held in Massachusetts over the past few months; together, they've raised nearly one million dollars in donations.
This is a developing story. Check back for updates as more information becomes available.
Download the FREE Boston 25 News app for breaking news alerts.
Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
an hour ago
- Fox News
A New Approach To Driving Down Drug Prices
The cost of healthcare is a concern nationwide, but Arkansas is trying to lead the way in bringing price relief to patients, particularly when it comes to prescription drugs. Governor Sarah Huckabee Sanders recently signed a new law banning pharmacy benefits managers from owning and operating pharmacies in her state. PBMs are third-party companies that act as intermediaries or middlemen between insurance companies, big pharma, and pharmacies and are supposed to negotiate for lower costs through rebates and discounts. However, President Trump and his administration have recently called them out for helping to drive up the price of drugs in the country. Governor Sarah Huckabee Sanders joins the Rundown to explain her state's efforts to get prices down and how she hopes other states and the federal government will follow Arkansas's lead. While the President's tariff strategy and efforts to reshape what he sees as an unfair trade system have created some uncertainty on both Wall Street and Main Street, the latest jobs data suggest the labor market is holding steady. Many investors took Friday's May jobs report as a sign that a recession isn't imminent. However, the housing market, inflation, interest rates, and other factors are still a concern. FOX Business Network's Gerri Willis joins the Rundown to discuss the state of the economy, including why she believes the housing market is under pressure but remains optimistic about the American consumer. Plus, commentary from RNC Youth Advisory Council Chair, Brilyn Hollyhand. Learn more about your ad choices. Visit
Washington Post
an hour ago
- Washington Post
Mothers report worse mental health in new report
More American mothers reported worse mental health in 2023 than in 2016 in a national survey, though many said they were in good health, according to a study in JAMA Internal Medicine. Using data from the National Survey of Children's Health, researchers analyzed self-reported mental health ratings from some 198,000 mothers with children age 17 and younger. In 2023, 26 percent of the mothers who responded said their mental health was 'excellent,' compared with 38 percent of mothers in 2016. While 19 percent of mothers reported good mental health in 2016, some 26 percent said the same in 2023.
Medscape
an hour ago
- Medscape
Youth Overdose Deaths From Synthetic Opioids Surge
While youth overdose deaths from any substance rose by 40% between 2018 and 2022, deaths involving only synthetic opioids, such as fentanyl, increased by 168% and surpassed deaths from polydrug combinations, a new study showed. METHODOLOGY: The National Center for Health Statistics, National Vital Statistics System, and Multiple Cause of Death datasets were used to examine trends in overdose deaths among US youth aged 15-24 years from 2018 to 2022 across ages, sexes, races and ethnicities, and regions. Researchers identified drug poisoning deaths through the International Statistical Classification of Diseases and Related Health Problems, 10th Revision . . Fatal overdoses involving synthetic opioids alone or in combination with benzodiazepines, cocaine, heroin, prescription opioids, and other stimulants were analyzed using multiple/contributing cause of death fields. Investigators calculated the prevalence and rates of overdose per 100,000 youth using annual US Census Bureau population estimates by race and ethnicity. TAKEAWAY: Youth overdose deaths from any substance increased from 4652 to 6723 (10.9 to 15.2 per 100,000 people) between 2018 and 2022. Fatal overdoses involving only synthetic opioids increased from 1.6 to 4.3 deaths per 100,000 youth over the same period, whereas deaths involving synthetic opioids and heroin decreased by 85%. In 2022, males had 2.5 times the rate of fatal overdoses involving synthetic opioids alone compared to females (95% CI, 2.3-2.8), with both sexes showing similar increases over the study period. By 2022, fatal overdoses involving only synthetic opioids among American Indian/Alaska Native non-Hispanic youth increased to 2.3 times the rate compared to White non-Hispanic youth (95% CI, 1.6-3.1). The highest annual changes in rate of overdose deaths involved synthetic opioids and other stimulants (incidence rate ratio [IRR], 1.5; 95% CI, 1.3-1.7), synthetic opioids only (IRR, 1.3; 95% CI, 1.1-1.4), and synthetic opioids and cocaine (IRR, 1.2; 95% CI, 1.2-1.3). IN PRACTICE: 'Before we looked at the data, we thought we would find that the majority of fatal youth overdoses involved fentanyl combined with other substances, such as prescription opioids or cocaine. Instead, we found the opposite — that most deaths were caused by fentanyl alone,' study co-investigator Noa Krawczyk, PhD, New York University Grossman School of Medicine, New York City, said in a press release. 'These findings highlight the changing risks of the drug supply and the need for better access to harm-reduction services to prevent deaths among youth,' the investigators wrote. SOURCE: This study was led by Megan Miller, MPH, Department of Population Health, New York University Grossman School of Medicine, New York City. It was published online on May 20 in Pediatrics . LIMITATIONS: This study was limited by potential residual misclassification in mortality coding practices, small sample sizes for examining youth who identify as more than one race, and lack of information about sexual orientation. DISCLOSURES: This study was supported by the National Institute on Drug Abuse. Krawczyk reported receiving compensation for expert witness testimony as a part of ongoing opioid litigation. The other investigators reported having no relevant financial disclosures.
